Skip to main content
U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Search help

52 results

  1. Studies Excluded at the Full-Text Review Stage - Nonpharmacological Versus Pharmacological Treatments for Adult ... 
    https://www.ncbi.nlm.nih.gov/books/NBK338246
    ... M, Karamati M, et al. Eicosapentaenoic acid versus docosahexaenoic acid in mild-to-moderate depression: A randomized, double- ... meta-analysis of depression, quality of life, and safety outcomes. PLoS Med. 2013; 10 (3):e1001403. Epub: ...
  2. Excluded Studies - Common Syndromes in Older Adults Related to Primary and Secondary Prevention - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK62083
    ... al. Validity of estimated dietary eicosapentaenoic acid and docosahexaenoic acid intakes determined by interviewer-administered food frequency questionnaire ...
  3. Introduction - Assessing the Impact of AHRQ Evidence-Based Practice Center (EPC) Reports on Future Research - NCBI ... 
    https://www.ncbi.nlm.nih.gov/books/NBK62156
    ... of ALA with EPA+DHA [eicosapentaenoic acid and docosahexaenoic acid]. The relative effect of ALA versus fish oil ...
  4. PHARMACOLOGICAL AND OTHER PHYSICAL TREATMENTS IN THE MANAGEMENT OF BORDERLINE PERSONALITY DISORDER - Borderline ... 
    https://www.ncbi.nlm.nih.gov/books/NBK55400
    ... omega-3 fatty acids, eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) have important biological functions in the CNS ; ...
  5. Included References - Diagnosis and Treatment of Clinical Alzheimer’s-Type Dementia: A Systematic Review - NCBI ... 
    https://www.ncbi.nlm.nih.gov/books/NBK556548
    ... Quinn JF, Raman R, Thomas RG, et al. Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a ...
  6. Excluded References - Diagnosis and Treatment of Clinical Alzheimer’s-Type Dementia: A Systematic Review - NCBI ... 
    https://www.ncbi.nlm.nih.gov/books/NBK556577
    ... blood-brain barrier after dietary supplementation with a docosahexaenoic acid-rich omega-3 fatty acid preparation in patients ... 24. Gelmont D, Dyck-Jones J, Aryan Z. Safety of intravenous immunoglobulin therapy in patients with probable ...
  7. List of Excluded Studies - Screening for Cognitive Impairment in Older Adults: An Evidence Update for the U.S. ... 
    https://www.ncbi.nlm.nih.gov/books/NBK554648
    ... CrossRef ] 278. Lee, LK, Shahar, S, et al. Docosahexaenoic acid-concentrated fish oil supplementation in subjects with mild ...
  8. References - Dementia - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK536508
    ... Quinn JF, Raman R, Thomas RG, et al. Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a ...
  9. Detailed Tables of Findings - Medical Therapies for Children With Autism Spectrum Disorder—An Update - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK448251
    ... RG, Mellon MW, Katusic SK, et al. Dietary docosahexaenoic acid supplementation in children with autism. J Pediatr Gastroenterol ... blind, placebo-controlled clinical trial of efficacy and safety. Clin Neuropharmacol. 2015 Jan–Feb;38(1):11– ...
  10. Risk of Bias Ratings - Medical Therapies for Children With Autism Spectrum Disorder—An Update - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK448253
    ... RG, Mellon MW, Katusic SK, et al. Dietary docosahexaenoic acid supplementation in children with autism. J Pediatr Gastroenterol ...
first · previous · 1 · 2 · 3 · 4 · 5 · 6 · next · last